comparing the ef fi cacy and safety of dose-ranging voclosporin with p A randomized , controlled double-blind study lacebo in achieving remission in patients with active lupus nephritis

lacebo in achieving remission in patients with active lupus nephritis Brad H. Rovin, Neil Solomons, William F. Pendergraft III, Mary Anne Dooley, James Tumlin, Juanita Romero-Diaz, Lidia Lysenko, Sandra V. Navarra and Robert B. Huizinga; for the AURA-LV Study Group Department of Internal Medicine–Nephrology, Ohio State University, Columbus, Ohio, USA; Aurinia Pharmaceuticals, Victoria, Canada; University of North Carolina Kidney Center, Chapel Hill, North Carolina, USA; GA Nephrology, Atlanta, Georgia, USA; Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, Mexico City, Mexico; First Moscow State Medical University, Moscow, Russia; and St. Luke’s Medical Center and University of Santo Tomas Hospital, Philippines